impact view report mix quarter revenu in-lin
mse adj ebitda adj ep beat mse although
headlin result expect given recent stock
out-performance believ extend valuat unchang
guidanc mix result segment level financi market
view quarter skew neg organ revenu growth in-lin
mse segment organ revenu mix transport
vs mse vs mse strong financi market
vs mse vs mse expect within
resourc upstream saw weak north america off-set strength
downstream continu cautiou
growth outlook given neg energi industri capital-expenditure
project rystad model vs
correl data resources/energi growth rate
past year financi market report organ revenu growth
expect inform process solut report mse
solut particularli concern organ growth vs mse given
strongest sub-seg averag organ growth sinc
prior ipreo post strong quarter organ growth
remain uw stock trade -turn analyt peer ex
standard ev/ebitda despit lower top-lin growth ntm
organ vs peer follow model updat maintain dcf-
base pt
recap revenu in-lin mse beat adj ebitda adj
ep due broad base margin expans transport
subscript organ growth non-subscript organ growth
downstream price opu chemic contribut strong
quarter upstream impact soft north america off-set strength
intern market transport organ growth strong
subscript organ growth non-subscript organ growth
servic organ growth led recur organ revenu
growth off-set non-recur growth adj ebitda margin expand
bp y/i beat mse adj ep mse
compani trade less week
unless otherwis note metric base modelwar
base consensu methodolog
consensu data provid thomson reuter estim
seek busi
compani cover morgan stanley research
result investor awar firm may
conflict interest could affect object
morgan stanley research investor consid
morgan stanley research singl factor make
invest decis
analyst certif import disclosur
refer disclosur section locat end
sell gener administr ex sbc
total revenu
restructur offer acquisit cost credit
incom equiti investment/shar jv/other
depreci amort
net incom common stockhold
deriv discount cash ow valuat wacc risk-fre rate
market risk premium beta termin growth rate base case
lead supplier
vertic attract busi model
believ current elev valuat
standard ev/ebitda
growth
segment highli
correl upstream energi capital-expenditure
expect neg base
rystad forecast
dcf-base pt impli downsid
view descript risk reward theme
organ revenu growth
compound-annual-growth-rate adj ebitda margin
encompass higher growth rate
oper margin base case
organ revenu growth
compound-annual-growth-rate adj ebitda margin
growth lacklust
energi environ continu
moder margin benet scale
organ revenu growth
compound-annual-growth-rate adj ebitda margin
industri vertic especi
lower oper margin
base case
margin expansiondriven cost synergi scale
platform initi
price wallet share product develop
china india
view explan region hierarchi
research highest favor quintil
innov financi servic lead higher-
acquisit prove dilutive/low growth
expect
fund exposur held mspb inform may
inconsist may reect broader market
exposur sector total net exposur
across sector long exposur short exposur
sell gener administr ex sbc
total revenu
restructur offer acquisit cost credit
stock-bas compens expens includ
loss sale asset net
net period pension post-retir benefit
incom equiti invest
incom loss discontinu oper net
total revenu
sale asset net
non-cash net period pension post-retir benefit
incom equiti investment/shar jv/other
lloyd register-fairplay
loss discontinu oper net
depreci amort
total revenu
net incom continu oper minor
incom equiti invest
minor interest
net incom continu oper
incom loss discontinu oper net
net incom common stockhold
restructur charg credit acquisition-rel cost
sale asset net
non-cash net period pension post-retir benefit
loss discontinu oper net
amort relat acquir intang asset
sell gener administr ex sbc
total revenu
restructur offer acquisit cost credit
stock-bas compens expens includ
loss sale asset net
net period pension post-retir benefit
incom equiti invest
incom loss discontinu oper net
total revenu
sale asset net
non-cash net period pension post-retir benefit
incom equiti investment/shar jv/other
lloyd register-fairplay
loss discontinu oper net
depreci amort
total revenu
net incom continu oper minor
incom equiti invest
minor interest
net incom continu oper
incom loss discontinu oper net
net incom common stockhold
restructur charg credit acquisition-rel cost
sale asset net
non-cash net period pension post-retir benefit
loss discontinu oper net
amort relat acquir intang asset
exhibit quarterli revenu segment
exhibit statement flow
net incom loss common stockhold
loss sale asset net
impair asset
impair asset discontinu oper
distribut equity-method invest
net non-cash period pension post-retir benefit
undistribut earn equity-method invest net
excess tax benefit stock-bas compens
net cash provid oper activ
chang asset liabil
capit expenditur properti equip
chang asset liabil
settlement forward contract
purchas invest
sale matur invest
acquisit busi net cash acquir
proce sale asset invest affili
net cash use invest activ
proce borrow
repay borrow
tax benefit equiti compens plan
purchas treasuri stock
proce exercis employe stock options/oth
net cash provid use financ activ
net increas decreas equival
cash equival
properti equip net
addit paid capit
accumul comprehens loss incom
chang work capit
free cash flow oper
present valu termin valu
present valu cash flow
-est net debt pye
impli valu per share begin year
